RFG Advisory LLC Has $1.75 Million Holdings in CVS Health Corporation $CVS

Key Points

• RFG Advisory LLC increased its stake in CVS by 315.4% in Q4 to 21,998 shares worth $1.746 million.
• CVS beat Q1 estimates (EPS $2.57 vs. $2.21; revenue $100.4B vs. $94.99B) and raised FY2026 adjusted EPS guidance to $7.30–$7.50, spurring multiple analyst price‑target increases and buy reiterations.
• CVS pays a quarterly dividend of $0.665 (annualized $2.66, ~3.0% yield) but has a high payout ratio of 192.8%, while institutional investors own about 80.7% of the stock.

RFG Advisory LLC increased its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 315.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,998 shares of the pharmacy operator's stock after acquiring an additional 16,702 shares during the quarter. RFG Advisory LLC's holdings in CVS Health were worth $1,746,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in CVS. National Pension Service raised its holdings in shares of CVS Health by 3.1% in the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator's stock valued at $301,532,000 after purchasing an additional 119,189 shares during the last quarter. Kingsview Wealth Management LLC grew its stake in shares of CVS Health by 316.2% in the third quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator's stock valued at $7,873,000 after acquiring an additional 79,340 shares in the last quarter. AE Wealth Management LLC grew its stake in shares of CVS Health by 6.2% in the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator's stock valued at $19,391,000 after acquiring an additional 14,983 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in CVS Health by 11.2% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator's stock worth $16,971,000 after purchasing an additional 22,653 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its stake in shares of CVS Health by 186.6% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator's stock valued at $30,568,000 after buying an additional 258,050 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

NYSE CVS opened at $87.34 on Friday. The company has a market cap of $111.93 billion, a P/E ratio of 38.47, a P/E/G ratio of 0.91 and a beta of 0.60. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.63 and a current ratio of 0.87. The business's 50 day moving average price is $76.86 and its 200-day moving average price is $78.03. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $88.63.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.21 by $0.36. The business had revenue of $100.43 billion for the quarter, compared to the consensus estimate of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The business's revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.25 EPS. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Sell-side analysts predict that CVS Health Corporation will post 7.14 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.0%. CVS Health's dividend payout ratio is currently 192.75%.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Q1 earnings and guidance beat — CVS reported Q1 adjusted EPS of $2.57 and revenue of $100.4B, topped estimates and raised full‑year 2026 adjusted EPS guidance to $7.30–$7.50, driven by insurance margin improvement and reserve benefits. This is the primary catalyst lifting the stock. CVS Health raises 2026 forecast after improving medical cost controls
• Positive Sentiment: Broker optimism and price-target increases — Multiple firms (Truist, UBS, DA Davidson, Deutsche Bank and others) bumped price targets and reiterated/maintained buy ratings, signaling analyst confidence that improved insurance performance and guidance justify higher valuation. Benzinga Deutsche Bank adjusts CVS Health price target DA Davidson raises price target
• Positive Sentiment: Improving insurance (Aetna) profitability — Management cited lower medical benefit ratios and better cost controls in government plans; Aetna’s turnaround is driving margin expansion and was highlighted repeatedly on the call. CVS blows past estimates, hikes outlook as insurance business outperforms
• Positive Sentiment: Retail operations showing strength — Increased prescription volume and retail pharmacy trends supported revenue growth and margin expansion, reinforcing the diversified earnings base. CVS’s increased prescription volume leads to solid Q1
• Neutral Sentiment: Strategic initiatives (biosimilars, AI, community programs) — CVS announced wider biosimilar formulary adoption and AI-driven affordability programs that could lower costs and boost long‑term margins, but near‑term impact is gradual. CVS Health Bets On Biosimilars And AI To Support Affordable Care
• Neutral Sentiment: Economic/PR pieces — Reports on CVS’s large national economic footprint and community programs support brand and regulatory goodwill but have limited immediate share‑price impact. CVS Health's Annual Impact in Connecticut
• Negative Sentiment: Valuation and structural PBM concerns — Some analysts and industry pieces warn that a temporary insurance profitability tailwind may mask longer‑term margin pressure in the PBM/business transformation, suggesting upside may be capped until sustainable improvement is proven. How CVS Health's Transformation Is Facing A Hard Valuation Floor

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Leerink Partners reissued an "outperform" rating and issued a $98.00 price target on shares of CVS Health in a research report on Thursday, March 5th. Robert W. Baird boosted their price objective on CVS Health from $92.00 to $94.00 and gave the stock an "outperform" rating in a report on Wednesday, April 15th. DA Davidson upped their price objective on shares of CVS Health from $80.00 to $100.00 and gave the company a "buy" rating in a research note on Thursday. Wolfe Research cut their price objective on shares of CVS Health from $100.00 to $97.00 and set an "outperform" rating for the company in a research note on Monday, March 2nd. Finally, UBS Group raised their price target on CVS Health from $97.00 to $100.00 and gave the stock a "buy" rating in a research note on Thursday. Twenty-two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, CVS Health has an average rating of "Moderate Buy" and a consensus target price of $95.88.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.